McKesson Corporation Cash Flow Conversion Efficiency
McKesson Corporation cash flow conversion efficiency. Based on the latest financial reports, McKesson Corporation (MCK) has a cash flow conversion efficiency ratio of 0.057x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-220.00 Million) by net assets ($-3.86 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of McKesson Corporation (1995–2026)
Cash flow conversion efficiency of McKesson Corporation from 1995 to 2026. This chart illustrates how McKesson Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MCK live share price for real-time trading data and today's change.
McKesson Corporation Cash Flow Conversion Ratio Explained
McKesson Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
McKesson Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of McKesson Corporation ranked by their cash flow conversion efficiency. Also see McKesson Corporation stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UBS Group AG
SW:UBSG
|
-0.043x |
|
CME Group Inc
NASDAQ:CME
|
0.047x |
|
Pinduoduo Inc
F:9PDA
|
0.039x |
|
INTESA SANPAOLO ADR/6
F:IESJ
|
N/A |
|
GSK PLC SP. ADR/2 NEW
F:GS70
|
0.157x |
|
EssilorLuxottica S. A.
PA:EL
|
0.136x |
|
Air Liquide SA
PA:AI
|
0.130x |
|
General Dynamics Corporation
NYSE:GD
|
0.070x |
Annual Cash Flow Conversion Efficiency for McKesson Corporation (1995–2026)
The table below shows the annual cash flow conversion efficiency of McKesson Corporation from 1995 to 2026. Review McKesson Corporation (MCK) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $-834.00 Million | $6.16 Billion | -7.380x | -105.45% |
| 2025-03-31 | $-1.69 Billion | $6.08 Billion | -3.592x | -33.14% |
| 2024-03-31 | $-1.60 Billion | $4.31 Billion | -2.698x | +22.08% |
| 2023-03-31 | $-1.49 Billion | $5.16 Billion | -3.462x | -39.93% |
| 2022-03-31 | $-1.79 Billion | $4.43 Billion | -2.474x | -178.77% |
| 2021-03-31 | $1.45 Billion | $4.54 Billion | 3.141x | +381.93% |
| 2020-03-31 | $6.71 Billion | $4.37 Billion | 0.652x | +56.32% |
| 2019-03-31 | $9.68 Billion | $4.04 Billion | 0.417x | +10.51% |
| 2018-03-31 | $11.52 Billion | $4.34 Billion | 0.377x | +0.21% |
| 2017-03-31 | $12.60 Billion | $4.74 Billion | 0.377x | +6.78% |
| 2016-03-31 | $10.41 Billion | $3.67 Billion | 0.353x | +7.31% |
| 2015-03-31 | $9.47 Billion | $3.11 Billion | 0.329x | +8.11% |
| 2014-03-31 | $10.32 Billion | $3.14 Billion | 0.304x | -13.46% |
| 2013-03-31 | $7.07 Billion | $2.48 Billion | 0.351x | -18.68% |
| 2012-03-31 | $6.83 Billion | $2.95 Billion | 0.432x | +33.36% |
| 2011-03-31 | $7.22 Billion | $2.34 Billion | 0.324x | +5.31% |
| 2010-03-31 | $7.53 Billion | $2.32 Billion | 0.307x | +40.95% |
| 2009-03-31 | $6.19 Billion | $1.35 Billion | 0.218x | +53.66% |
| 2008-03-31 | $6.12 Billion | $869.00 Million | 0.142x | -42.13% |
| 2007-03-31 | $6.27 Billion | $1.54 Billion | 0.245x | -47.19% |
| 2006-03-31 | $5.91 Billion | $2.74 Billion | 0.465x | +59.29% |
| 2005-03-31 | $5.28 Billion | $1.54 Billion | 0.292x | +167.37% |
| 2004-03-31 | $5.17 Billion | $563.40 Million | 0.109x | -25.90% |
| 2003-03-31 | $4.72 Billion | $695.50 Million | 0.147x | +84.89% |
| 2002-03-31 | $4.14 Billion | $329.30 Million | 0.080x | -16.83% |
| 2001-03-31 | $3.69 Billion | $353.10 Million | 0.096x | +186.55% |
| 2000-03-31 | $3.76 Billion | $-416.00 Million | -0.111x | -207.33% |
| 1999-03-31 | $3.08 Billion | $317.10 Million | 0.103x | +7404.23% |
| 1998-03-31 | $1.60 Billion | $2.20 Million | 0.001x | -99.16% |
| 1997-03-31 | $1.46 Billion | $238.10 Million | 0.164x | +7239.94% |
| 1996-03-31 | $1.12 Billion | $2.50 Million | 0.002x | -98.77% |
| 1995-03-31 | $1.07 Billion | $195.10 Million | 0.182x | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more